Stemtree of Spring TX is excited to introduce a new educational program aimed at young learners. This program focuses on subjects like science, technology, engineering, and math (STEM). It offers interactive learning experiences to spark curiosity and improve problem-solving skills in kids.
The center is known for its unique way of teaching, encouraging students to dive into hands-on activities. These activities help them grasp complex topics more easily. There’s a growing importance for STEM subjects in our technology-focused society, making this approach all the more beneficial.
At Stemtree of Spring TX, the curriculum focuses on personalized learning. Kids can move at their own pace, ensuring they fully understand each topic. This tailored method helps meet the specific educational needs of every student.
“Stemtree of Spring TX provides a new way to learn, where students can dive into an inquiry-based setting,” said Luis Miranda of Stemtree of Spring TX. “We believe this approach not only boosts knowledge but also builds young learners’ confidence.”
The teaching style combines one-on-one tutoring with group activities to create a balanced experience. This helps support collaborative learning while catering to individual learning preferences. Kids have the chance to delve into topics like robotics, coding, and lab sciences, helping them find their interests and strengths.
Stemtree of Spring TX offers a flexible schedule with both after-school and weekend sessions. This flexibility makes the program more accessible and allows parents to involve their children in valuable educational experiences outside the regular classroom.
“We see how kids learn best by actively engaging with the material,” said Miranda. “STEM education in Spring TX makes learning come alive, making it both enjoyable and meaningful.”
The facility boasts modern tools and resources to offer a well-rounded learning experience. By providing access to the latest technologies, Stemtree of Spring TX aligns with contemporary educational standards and helps prepare students for future challenges in STEM fields.
Alongside regular classes, Stemtree of Spring TX hosts special events and workshops that cover current advancements in science and technology. These events are designed to broaden students’ understanding and show them real-world applications of what they learn. More information about upcoming events and workshops can be found on the Stemtree website.
The team at Stemtree of Spring TX consists of experienced educators focused on nurturing a love of learning in their students. They aim to inspire the next wave of innovators and thinkers, providing a strong foundation for lifelong learning and success in emerging careers.
The center is committed to offering a safe and supportive learning environment. By prioritizing safety and educational quality, they ensure students can focus on their studies and enjoy their educational journey.
In conclusion, Stemtree of Spring TX is launching an educational program that aims to make a real difference for young learners. Through engaging activities and a personalized approach, the program seeks to inspire a love for STEM subjects. With interactive and practical learning experiences, Stemtree of Spring TX is paving the way for a more inventive and impactful future in education. To learn more about how to get involved, visit their official website.
Carrot LASIK & Eye Center is shedding light on one of the most important but often overlooked aspects of refractive surgery—the material used in the implantable lens itself. In its latest article, EVO ICL Materials: Why Collamer Makes the Difference, the Mesa, Arizona-based practice outlines how the unique composition of Collamer contributes to the long-term safety, performance, and patient satisfaction of the EVO ICL procedure. For individuals who are not candidates for LASIK due to thin corneas, high myopia, or other concerns, EVO ICL represents a proven, minimally invasive solution—and the lens material plays a critical role in that success.
Unlike traditional corrective procedures that reshape or remove corneal tissue, EVO ICL (Implantable Collamer Lens) is placed inside the eye, preserving the integrity of the cornea. The key to its compatibility and effectiveness lies in Collamer, a proprietary material composed of purified collagen, poly-HEMA, water, and a UV-absorbing chromophore. Carrot LASIK & Eye Center emphasizes that this material was specifically engineered to work in harmony with the natural anatomy of the human eye. Patients benefit from a lens that is soft, flexible, and highly biocompatible—important characteristics that help reduce inflammation, discomfort, and long-term complications.
One of the standout properties of Collamer is its ability to attract fibronectin, a naturally occurring protein that forms a protective layer on the lens surface. This helps shield the implant from being targeted by the body’s immune system, minimizing inflammatory responses and lowering the risk of visual impairment due to protein buildup. Additionally, Collamer carries a slight negative ionic charge, which repels unwanted protein deposits in the aqueous humor. These features collectively help maintain long-term clarity and comfort for patients who choose EVO ICL over more traditional vision correction methods.
Another major advantage of Collamer is its optical performance. Because the material closely mimics the refractive qualities of the natural lens and integrates well with the internal structures of the eye, it delivers sharp, stable vision across a wide range of prescriptions. At Carrot LASIK & Eye Center, patients who previously relied on strong glasses or contact lenses have reported dramatic improvements in visual acuity and quality of life after undergoing EVO ICL. The procedure is particularly beneficial for individuals with high myopia or astigmatism, for whom other surgical options may not be suitable or safe.
In a region with abundant sunlight like Arizona, UV protection is another critical factor in long-term eye health. Carrot LASIK & Eye Center highlights that Collamer’s built-in UV-blocking component offers protection from harmful rays that can contribute to the development of cataracts and other degenerative conditions. While sunglasses can help, having an intraocular lens with embedded UV filtration provides an added layer of defense—especially for patients who are active outdoors or spend long hours in bright environments.
EVO ICL also offers distinct advantages over older implant materials like acrylic or silicone. These older materials can be stiffer and more prone to irritating the surrounding tissues, leading to discomfort and a higher rate of postoperative complications. In contrast, the flexibility and softness of Collamer allow the lens to be inserted through a smaller incision, which reduces surgical trauma and speeds up recovery. This also makes the procedure reversible—another key point that Carrot LASIK & Eye Center emphasizes during patient consultations. Should vision needs change in the future or if new technologies emerge, the lens can be removed or replaced without having altered the corneal structure.
For patients who are frustrated by the limitations of glasses and contact lenses—such as fogging, dryness, or frequent prescription changes—EVO ICL provides a reliable, low-maintenance alternative. Once implanted, the lens does not require care or replacement, and it eliminates the daily hassles associated with other corrective methods. Carrot LASIK & Eye Center uses advanced diagnostic tools, including corneal topography and wavefront analysis, to determine candidacy and ensure the best possible outcomes for each individual patient.
The article underscores that EVO ICL is not just a technical procedure—it’s a personalized solution designed to meet the long-term vision needs of patients who want freedom from glasses or contacts. And while many vision correction options exist, the material science behind EVO ICL makes it uniquely effective for patients who have been told they’re not a candidate for LASIK or PRK. At Carrot LASIK & Eye Center, the focus is always on what’s best for the patient’s long-term eye health and quality of life.
Reporters interested in covering advancements in refractive surgery or exploring the role of biomaterials like Collamer in ophthalmology are encouraged to reach out to Carrot LASIK & Eye Center for expert commentary or patient stories. With an experienced surgical team and a strong focus on individualized care, the practice is a trusted source for information on cutting-edge solutions like EVO ICL.
Patients who have been told they are not candidates for LASIK—or who are looking for a permanent, low-maintenance solution to correct nearsightedness or astigmatism—can schedule a consultation with Carrot LASIK & Eye Center to see if EVO ICL with Collamer is the right choice. The center’s approach combines advanced technology with a clear commitment to patient education, safety, and outcomes. By highlighting what sets EVO ICL and the Collamer material apart, this press release aims to bring awareness to a refractive option that many still don’t know exists—but should.
New Jersey commercial solar provider recognized by Solar Power World for seventh consecutive year
MAHWAH, NJ / ACCESS Newswire / August 6, 2025 / Core Development Group, a nationally ranked, independent, trusted clean energy provider, has ranked number 16 as the commercial contractor in the nation on Solar Power World‘s prestigious 2025 Top Solar Contractors List. Based on 2024 installed capacity (in kWDC), Core Development Group was at the top of the lists in 6 states, including ranked 16th overall in New Jersey, 44th in New York, and 7th in Connecticut. This marks the seventh consecutive year that Core Development Group has made the rankings.
Solar Power World chooses its annual list of Top Solar Contractors based on the total number of solar kilowatts installed, geographic reach, and market influence. Receiving this prestigious accolade for the seventh consecutive year underscores Core Development Group’s dedication to excellence, innovation, and sustainability in the clean energy sector. The Top Solar Contractors List is the most recognized annual listing of solar firms in the utility, commercial, community, and residential markets.
“Since our inception, we’ve been committed to helping businesses and organizations adopt cleaner and more affordable solar power solutions,” said Henry Cortes, founder and CEO of Core Development Group. “Solar Power World’s ranking of Core Development Group as a top commercial solar contractor reinforces our strong position in the solar industry and reflects our relentless drive to put our customers first and deliver operational excellence. As we continue to grow, we remain committed to our customers and stabilizing their energy budgets, reducing long-term energy costs and lowering their carbon footprint at the same time.”
Core Development Group has multiple commercial solar and battery energy storage system (BESS) projects in the pipeline. Solar power generation and battery storage add flexibility to any sustainable energy solution and are key to clean energy deployment across the USA.
“From the smallest residential projects to the largest utility-scale solar farms, these installations are keeping the lights on and keeping power affordable. We’re thrilled to recognize another outstanding class of Top Solar Contractors,” said Kelsey Misbrener, managing editor of Solar Power World.
As a full-service commercial solar company, Core Development Group manages the entire solar energy process. The past year was a banner year for the company, marked by a comprehensive portfolio of successful solar and battery projects. These installations not only enhance energy efficiency and lower carbon emissions but also deliver budget stability or cost savings to clients.
About Core Development Group Core Development Group is a trusted and agile independent U.S. renewable energy developer, contractor, and consultant. The company helps organizations transition to clean, renewable energy and provides solar energy systems, battery storage, microgrids, and EV charging infrastructure to companies in the U.S. and abroad. Core Development Group also provides world-class engineering, design, construction, quality assurance, and construction management consulting services for renewable energy projects. Founded in 2012, Core Development Group is headquartered in Mahwah, New Jersey. Learn more at coredevusa.com.
About Solar Power World Solar Power World is the leading online and print resource for news and information regarding solar installation, development and technology. Since 2011, SPW has helped U.S. solar contractors – including installers, developers, and EPCs in all markets – grow their businesses and do their jobs better.
About the Top Solar Contractors List The Top Solar Contractors List is the most recognized annual listing of solar contractors in the United States. It is compiled annually by industry magazine Solar Power World to recognize the work of solar installers to decarbonize the grid and support home-grown, local energy. Companies on the Top Solar Contractors List are grouped and listed by specific service, market (commercial, community solar, residential, utility), and state by 2024 installed capacity (in kWDC). See all the 2025 winners.
TaxFree RV is a leader in vehicle registration services, specializing in Montana LLC vehicle registration to offer significant tax savings. TaxFree RV is excited to announce a new service for RV owners interested in Montana registration. This initiative is designed to make the process easier for RV enthusiasts, easing the usual hassles of getting registered. By using this service, RV owners might gain some legal and tax perks tied to Montana registration.
Owning an RV comes with its share of responsibilities, including understanding registration laws. TaxFree RV Montana RV Registration provides clarity and support to guide owners through state-specific regulations. This service ensures that all necessary paperwork is correctly completed, minimizing the chances of legal troubles. As a trusted service, the company is dedicated to making registration a smooth and easy experience, which is a big benefit for RV owners.
TaxFree RV focuses on the needs of RV owners, tackling the typical challenges that come with the registration process. Montana is known for its favorable RV ownership laws, and TaxFree RV Montana RV Registration aims to make it easier for owners to access these benefits. With a team of seasoned professionals, the company assists clients every step of the way, helping them travel without worry.
“We are thrilled to offer a service that takes the stress out of the registration process for RV owners,” said the CEO of TaxFree RV. “Our aim is to make the experience as simple as possible, so our clients can focus on enjoying their travels instead of worrying about complex legal stuff.”
The benefits of registering an RV in Montana are well-known, and with the expertise of TaxFree RV, these perks are now more accessible. The service includes personalized consultations, offering RV owners detailed advice that matches their needs. By ensuring everything fits within Montana’s legal requirements, RV owners can head out on their travels with confidence.
TaxFree RV has earned its reputation by guiding many clients through the complicated vehicle registration process. The company’s commitment to customer satisfaction shines through in its thorough and attentive service. Clients often express their satisfaction with how TaxFree RV handles registration, trusting them for accurate and reliable results. Plus, because of Montana’s favorable laws, the money saved through TaxFree RV’s services can be significant for RV owners.
This new service includes helping with documentation to make sure all legal criteria are met. This means RV owners can focus on their trips instead of paperwork. The initiative not only celebrates Montana’s RV-friendly rules but also stresses the importance of managing registration properly to avoid unexpected issues.
“Our team makes registering RVs in Montana a breeze, providing an easy process for our clients,” stated a company spokesperson. “We are committed to delivering expert advice and efficient service, empowering RV enthusiasts to spend more time enjoying the road.”
With the inclusion of registered agent services, TaxFree RV ensures that all legal correspondences related to vehicle registrations are handled efficiently. This service can be further explored on their platform, which details their agent services and the broad spectrum of vehicles they cover, such as boats, motorcycles, and UTVs.
TaxFree RV believes this new service will open up more opportunities for RV owners across the country, providing a strong solution for those curious about Montana registration benefits. This initiative highlights the company’s role as a leading provider of RV registration services, offering clients a straightforward way to enjoy state-specific advantages.
The launch of this initiative shows TaxFree RV’s dedication to improving the RV ownership experience by meeting the unique needs of its clients through personalized solutions. By focusing on clarity and ease, the company ensures their clients get the help they need to make smart choices about their RV registrations.
Overall, the introduction of TaxFree RV Montana RV Registration aims to change how RV owners deal with registration. Anyone interested should reach out to the company to learn more about the possible benefits. As the word spreads about this service, TaxFree RV stays committed to creating an easy, supportive environment for RV fans, highlighting the importance of expert help in vehicle registration.
Atlas Remodeling, a well-known home remodeling company in Central Pennsylvania, has announced a special promotion to make their top-notch services more affordable. For over 30 years, Atlas Remodeling has specialized in bathroom replacements, window replacements, and door installations, earning a solid reputation for quality and customer-focused solutions.
Gerald Miller, a representative from Atlas Remodeling, shared, “We are thrilled to introduce this new promotion aimed at making our high-quality services more accessible to homeowners. Whether it’s updating a bathroom, replacing old windows, or installing new doors, we want every customer to have the home of their dreams without the financial burden.”
Atlas Remodeling stands out for its dedication to enhancing both the functionality and look of homes. They emphasize straightforward processes that are easy for customers to navigate. Their latest promotion aims to offer a smooth experience for homeowners interested in comprehensive bathroom remodeling services. From bathtub conversions to shower replacements, Atlas is committed to designing stylish and functional spaces that fit the unique preferences of each home.
In the area of window replacements, Atlas Remodeling offers a variety of choices such as bay, casement, and double-hung windows. They also provide options for energy-efficient glass along with different window colors, allowing each home to not only look better but also gain in energy efficiency. These improvements not only boost a home’s curb appeal but can also reduce energy costs.
Atlas Remodeling is also proficient in door installation, offering a wide range of styles that includes custom doors, entrance doors, sliding doors, and storm doors. The goal is to complement any home’s architectural needs and personal taste while ensuring enhanced security and an inviting exterior.
The company’s commitment goes beyond craftsmanship to comprehensive customer support throughout the remodeling journey. Offering free consultations and assistance with insurance claims, Atlas makes the process as hassle-free as possible. Their A+ rating from the Better Business Bureau reflects their dedication to providing excellent service and ensuring customer satisfaction.
Besides their professional services, Atlas Remodeling is active in the community, supporting local initiatives and charities. This involvement demonstrates their belief in not only upgrading homes but also giving back to the communities they serve.
Gerald Miller adds, “We believe in growing with our community and serving as a reliable partner in home enhancement. This new promotional effort aligns with our goal to offer exceptional services that are attainable for every homeowner.”
Those looking for genuine customer feedback can turn to Atlas Remodeling Harrisburg Reviews, full of positive experiences and testimonials. One review highlighted the company’s ability to transform an outdated bathroom into a modern, accessible shower space, complete with essential safety features. This project showcases Atlas’s focus on practical design and innovation.
As more people show interest in remodeling, the demand for quality service providers like Atlas Remodeling also increases. Their experience, wide range of services, and customer-first approach sets them apart in the market.
This new promotion provides a timely chance for homeowners to upgrade their properties, especially with any upcoming seasonal changes. Whether looking to update bathrooms, install new windows, or improve door options, Atlas Remodeling is ready to deliver excellent results that enrich homes and ensure customer happiness.
Additionally, the Atlas Remodeling Facebook page is a great resource for those interested in more customer feedback and updates on ongoing projects. The company frequently shares photos and success stories there, offering potential clients a glimpse of the possibilities for their own home improvements.
As the year goes on, homeowners are encouraged to look into the options offered by Atlas Remodeling. By taking advantage of these promotional services, they can confidently undertake projects with the expertise and care that defines Atlas, keeping them a leader in home enhancement services in the region.
For those interested in learning more about their window solutions, visit the Atlas Remodeling website where detailed information and galleries of their completed projects are available.
Essential Reading for HR Leaders, DEI Professionals and Executives Navigating Inclusion Efforts in a Shifting Legal and Political Climate
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / August 6, 2025 / Introducing “Reimagining Fairness: An Equity, Cultural Diversity, and Inclusion Competency Approach,” the latest release from internationally recognized cognitive cultural psychologist and organizational change strategist Dr. Billy E. Vaughn. Arriving at a critical moment amid growing legal and political pressures on equity efforts, this timely book delivers a groundbreaking, practical framework for embedding fairness into organizational culture, leadership, and talent management. Dr. Vaughn’s approach equips organizations to advance equity in ways that are not only sustainable, but also resilient to legal and regulatory challenges.
What Sets This Book Apart
While most DEI books focus on increasing representation, offering standard diversity training or holding leaders accountable, Reimagining Fairness takes a bold direction few have taken. It introduces the Equity, Cultural Diversity, and Inclusion (ECDI) Competency Framework – a practical philosophy and strategic method that goes beyond implementing legally vulnerable best practices. This framework directly connects fairness to organizational objectives, bottom line, and long-term success, making equity an integral part of how organizations achieve and sustain their goals while managing risk.
“This book is not about checking boxes. It’s about making fairness part of how organizations lead, operate, succeed.” – Dr. Billy Vaughn
Key Features
A decisive shift from equality values to equity-driven fairness aligned with legal defensibility and cultural change
The ECDI Framework for leaders and HR professionals
Real-world examples from transit agencies, universities, and corporate environments
Tools for implementation: KPI templates, assessment checklists, and more
Endorsement by pioneers, such as Dr. Edward E. Hubbard, an expert in DEI analytics, and Dr. Judith Katz, an expert in organizational change
Who Should Read This
C-suite executives and DEI officers
HR leaders and change managers
Organizational change experts and teachers
Public agency administrators
Nonprofit and higher education leaders
Diversity consultants and scholars
Author Bio
Dr. Billy E. Vaughn is the visionary founder of Diversity Training University International (DTUI.com) and the Diversity Executive Leadership Academy (DELA). He also serves as publisher of Diversity Officer Magazine. With three decades of experience, Dr. Vaughn has been a trusted advisor to leading corporations, healthcare institutions, universities, and government agencies, guiding them in embedding fairness and equity throughout their organizational systems. Since launching the DELA academy in 1998, he has overseen the certification of several thousand diversity practitioners. Recognized by his peers as one of the top 100 influencers in the field, Dr. Vaughn is known for his robust social media presence and is widely regarded as a thought leader and innovator in diversity, equity, and inclusion.
Availability
Reimagining Fairness is available now on Amazon and other major bookselling platforms. Bulk orders, signed copies, and speaker requests can be arranged through DTUI.com.
Global Fintech Doubles Down on ESG Commitments to Build a More Sustainable and Inclusive Future
BOULDER, CO / ACCESS Newswire / August 6, 2025 / For the fourth consecutive year, global fintech, SumUp has reaffirmed its dedication to making a meaningful and lasting impact through its environmental initiatives.
Guided by its mission to champion small business ownership globally and its “3Es” framework – focusing on Environment, Education and Entrepreneurship, SumUp continues committed to initiatives that empower thousands of people around the world. Learn more about SumUp’s ESG efforts below:
Environmental Initiatives
Having already worked with Belgium-based NGO, River CleanUp, to remove 215 tons of plastic from the Citarum River since 2022, SumUp is pledging to remove a further 100 tons of plastic in 2025.
Together with Wilderness International, SumUp has helped protect 300,000 m2 of rainforest in Peru, preserving valuable habitats and biodiversity while offsetting 18,000 tons of CO2. SumUp is also supporting StoveTeam International to supply 3,000 families in Central America with safe, fuel-efficient cookstoves.
Education Initiatives
Since 2022, SumUp has been working with American NGO, Generation, to offer free Java Full Stack courses to unemployed minority youth across Brazil, Chile and Colombia, with over 80% of the graduates securing jobs in the tech industry.
In Brazil, SumUp is collaborating with Associação Comunitária MonteAzul, who provide 350 children each month in the MonteAzul favela with extracurricular activities, cultural projects and psychological care. Additionally, SumUp supported an initiative with Brazilian charity, CapacitaMe, to help 500 vulnerable individuals enter the labor market.
SumUp has worked with the Rusalya Association in Bulgaria to improve the quality of education for 50-70 socially disadvantaged children at the Dimitar Ekimov Boarding School of Arts and Crafts.
Entrepreneurship Initiatives
In partnership with DharmaLife, SumUp has made a positive impact on the lives of thousands of girls in rural India. Building on the success of the Lighting Up Young Minds program – a digital platform that delivers education to over 10,000 children each year – SumUp now also funds JAYA, an entrepreneurship-focused initiative.
SumUpco-founder, Marc-Alexander Christ comments: “As a global industry leader, we recognize the importance of empowering individuals worldwide to reach their full potential while championing environmental conservation efforts. In 2025 we’ve taken action to complete our first double materiality assessment and understand our carbon footprint in preparation for further ESG reporting, doubling down on our commitments to sustainability and social impact initiatives.”
About SumUp SumUp is a global financial technology company driven by the mission of empowering small businesses all over the world. Established in 2012, SumUp is the financial partner for more than 4 million entrepreneurs in over 35 markets worldwide.
In the United States, SumUp offers an ecosystem of affordable, easy-to-use financial products, such as point-of-sale and loyalty solutions, card readers, and invoicing.
Clinical data and cost-effectiveness analysis demonstrates the VenoValve would provide both better health outcomes and lower costs compared to current standard of care treatments
The VenoValve could potentially save $5.9 billion annually in healthcare costs for the approximately 2.5 million U.S. patients with severe CVI
Company to host live webcast with lead author of the cost-analysis manuscript, today, August 6th, at 12:00 PM ET; Access the Webcast Here
IRVINE, CA / ACCESS Newswire / August 6, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous disease, today announcedpreliminary findings from a VenoValve health economic study, which indicate that the VenoValve would be a cost-effective treatment option for patients with severe Chronic Venous Insufficiency (CVI) caused by deep valvular incompetency. The Company announced it will host a live webcast to discuss the cost-effectiveness analysis results today, Wednesday, August 6th at 12:00 PM ET (details below).
Key Findings from the Study Include:
VenoValve was dominant relative to standard of care (i.e., lower costs, higher quality-adjusted life years):
Cost savings: $32,442 per patient over 5 years
Clinical benefit: 2.2 ulcers avoided per patient
Quality of life: 0.33 additional QALYs gained per patient
Additional economic value associated with use of the VenoValve:
$14,912 saved per each venous ulcer avoided
$4,101 cost per each rVCSS point improvement
Break-even achieved between years 2-3
Results remained consistent across multiple sensitivity analyses and scenarios (different age populations, various assumptions), confirming the model’s reliability.
Mark H. Meissner M.D., surgeon at the Vascular and Endovascular Surgery Clinic at University of Washington (UW) Medical Center, a UW professor of Surgery, and the lead author of the manuscript added, “There remains a significant need for better treatment options for patients with severe, deep venous CVI, an advanced disease that affects millions of Americans annually and accounts for 1-2% of total healthcare expenditures, roughly ~$90 billion. These comprehensive economic analysis results, coupled with the robust clinical data demonstrated in the VenoValve U.S. pivotal trial, well positions the VenoValve to address the significant treatment gap while providing substantial economic value to the healthcare system.”
“There are several factors that need to align in order to promote wide adoption of a first-in-class medical device. Two of the more important factors are good clinical results, and a willingness to pay for the device and the procedure. This health economic study provides evidence that the VenoValve would be extremely cost-effective, resulting in substantial health cost savings over time. This cost-effectiveness data, together with the strong clinical evidence from the pivotal trial, make a compelling package for commercial payors such as private health insurance providers and employers, that often make coverage decisions based upon both clinical and cost-effectiveness data”, added Robert Berman, enVVeno Medical’s Chief Executive Officer.
While private payors generally make coverage decisions based upon clinical evidence and cost effectiveness, Medicare makes coverage decisions based upon clinical effectiveness to support reasonable and necessary criteria for the Medicare population.
As part of the health economic study, a de novo cost-effectiveness model was developed to simulate clinical and economic outcomes for patients with deep venous CVI caused valvular incompetence. The model structure was based on health states defined by the revised Venous Clinical Severity Score (rVCSS), which were derived from a post-hoc analysis of the one-year results from the VenoValve U.S. pivotal trial. Key input values for transition probabilities, clinical events, costs of care, and utilities were sourced from the pivotal trial and publicly available sources. Six-month cycles were assumed for the first year, to match the VenoValve pivotal trial, followed by annual cycles; outcomes were compared over a 5-year time horizon.A manuscript describing the full methodology and findings has been submitted for peer review and publication.
The VenoValve is a potential first-in-class, surgical replacement venous valve for patients with severe deep venous CVI. The Company estimates that approximately 2.5 million people in the United States could be candidates for the VenoValve, including approximately 1.5 million diagnosed with venous ulcers. The Company has submitted a pre-market authorization (PMA) application for the VenoValve to the U.S. Food and Drug Administration (FDA), with a decision anticipated in the second half of 2025.
Webcast Details
The Company will host a webcast presentation to discuss the results for investors, analysts and other interested parties today, August 6, 2025, at 12:00 PM ET. Joining enVVeno management for the event will be Dr. Meissner. The live webcast will be accessible on the Events page of the enVVeno website, envveno.com, and will be archived for 90 days.
About CVI
Severe deep venous CVI is a serious and debilitating disease that is most often caused by blood clots (deep vein thromboses or DVTs) in the deep veins of the leg. When valves inside of the veins of the leg fail, blood flows in the wrong direction and pools in the lower leg, causing pressure within the veins of the leg to increase (venous hypertension).
Symptoms of CVI include leg swelling, pain, edema, and in the most severe cases, recurrent open sores known as venous ulcers. The disease can severely impact everyday functions such as sleeping, bathing, dressing, and walking, and is known to result in high rates of depression and anxiety. There are currently no effective treatments that repair deep venous valve dysfunction, the #1 cause of severe CVI-a disease estimated to cost the U.S. healthcare system in excess of $26 billion each year.
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company’s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous CVI. The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVIcalled enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.
Cautionary Note on Forward-Looking Statements
This press release and any statements of stockholders, directors, employees, representatives and partners of enVVeno Medical Corporation (the “Company”) related thereto contain, or may contain, among other things, certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements identified by words such as “projects,” “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential” or similar expressions. These statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties, including those detailed in the Company’s filings with the Securities and Exchange Commission. Actual results and timing may differ significantly from those set forth or implied in the forward-looking statements. Forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company’s control). The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future presentations or otherwise, except as required by applicable law.
Trusted partners and experts for clients navigating the New York State of Health Marketplace join AmeriLife’s growing Health Distribution network
CLEARWATER, FL / ACCESS Newswire / August 6, 2025 / GS National Insurance, a wholesale distributor of health insurance products for independent brokers and agencies, and affiliate of AmeriLife, today announced a strategic partnership with Davies Agency, a leading Medicare and health brokerage based in Orchard Park, N.Y. Per the agreement, terms of the deal were not disclosed.
“We are very excited to partner with GS National Insurance and AmeriLife, respected leaders in the Medicare and insurance industry,” said Tom and Sue Davies, principals of Davies Agency, in a joint statement. “This strategic partnership marks an exciting chapter in our journey, allowing us to expand our services and deliver even greater value to our clients, partners, and community.”
For more than 20 years, Davies Agency has specialized in Medicare insurance and individual and family health plans offered through the New York State of Health Marketplace. The agency is known for its personalized approach to health insurance, offering comprehensive services that include navigating Medicare Advantage Plans, Medicare Supplement (Medigap) Insurance, Part D Prescription Drug Plans, Individual Coverage Health Reimbursement Arrangements (ICHRA), and more. Davies’ experienced agents, who offer face-to-face, concierge-level support, are trained to support clients with personalized support that takes the confusion out of Medicare and health insurance and helps them maximize benefits to fit their lifestyles.
The partnership with GS National and AmeriLife will provide enhanced support, expanded product offerings, and a broader range of solutions and services to agents to streamline their sales processes, grow their books of business, and serve even more clients across the region.
“It’s an honor to officially welcome Tom and Sue into our family,” said Brian Breisinger, founder, president, and CEO of GS National Insurance. “I’ve had the privilege of working alongside them for several years and have always admired their integrity, client-first mindset, and deep industry knowledge. This partnership represents a continuation of the values and service we both cherish.”
“We are thrilled to strengthen our Health Distribution family through this partnership with Davies Agency,” added Scotty Elliott, AmeriLife’s Chief Distribution Officer for Health. “Tom and Sue have built a reputation for excellence and personalized service, which aligns perfectly with AmeriLife’s commitment to providing best-in-class solutions for agents and their clients. This collaboration is yet another significant step forward in our mission to enhance the health and well-being of communities across the country.”
About Davies Agency
Davies Agency is a trusted health brokerage in Orchard Park, New York, dedicated to providing personalized support and guidance in navigating Medicare and health insurance options. Their experienced agents are committed to helping clients find the best plans and secure the lowest costs. To learn more, visit DaviesAgency.net.
About GS National Insurance
Founded in 2007, GS National Insurance, an affiliate of AmeriLife, is a national wholesale distributor of insurance products for independent brokers built on the belief that simplicity, transparency, and recognition are the cornerstones for success in the insurance industry. For more information, visit GSNational.com.
About AmeriLife
AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. AmeriLife develops, markets, and distributes life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For over 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers through a national distribution network of over 300,000 agents, financial professionals, and more than 160 marketing organizations and insurance agencies. For more information, visit AmeriLife.com and follow AmeriLife on Facebook and LinkedIn.
PLANO, TX / ACCESS Newswire / August 6, 2025 / BGSF, Inc. (NYSE:BGSF), a leading provider of workforce solutions through the Property Management segment, today reported financial results for the second fiscal quarter ended June 29, 2025.
Q2 2025 Highlights from Continuing Operations (results include sequential comparisons to Q1 2025):
Revenues were $23.5 million for Q2, compared to $20.9 million for Q1 . The 12.6% increase from Q1 is primarily driven by increased billed hours from seasonal demand.
Gross profit was $8.4 million for Q2, up from $7.6 million in Q1, primarily due to higher sales.
Net loss was $4.9 million, or $0.44 per diluted share for Q2, compared to a net loss of $2.2 million in Q1 or $0.21 per diluted share.
Adjusted EBITDA1 loss was $1.1 million (4.9% of revenues) in Q2 compared to $1.0 million (5.4% of revenues) in Q1.
Adjusted EPS1 loss was $0.19 for Q2, compared with Adjusted EPS1 loss of $0.11 for Q1.
SUMMARY OF FINANCIAL RESULTS FROM CONTINUING OPERATIONS (dollars in thousands) (unaudited)
For the Thirteen Week Periods Ended
June 29, 2025
June 30, 2024
March 30, 2025
Revenues
$
23,506
$
25,726
$
20,883
Gross profit
$
8,410
$
9,596
$
7,560
Gross profit percentage
35.8
%
37.3
%
36.2
%
Operating loss
$
(4,425
)
$
(1,475
)
$
(1,773
)
Net loss
$
(4,862
)
$
(2,082
)
$
(2,245
)
Net loss per diluted share
$
(0.44
)
$
(0.19
)
$
(0.21
)
Non-GAAP Financial Measures:
Adjusted EBITDA1
$
(1,145
)
$
(264
)
$
(1,032
)
Adjusted EBITDA Margin (% of revenue)1
(4.9)
%
(1.0)
%
(5.4)
%
Adjusted EPS1
$
(0.19
)
$
(0.04
)
$
(0.11
)
1 Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures as defined and reconciled below.
Interim Co-Chief Executive Officer, Chief Financial Officer and Secretary, Keith Schroeder, said, “The proposed sale of BGSF’s Professional division to INSPYR is moving along as planned, a proxy statement was filed on July 25th to call for a special meeting of shareholders on September 4th to vote on the transaction. Following the closing of the transaction, we will perform under a Transition Service Agreement, or TSA, for up to six months or longer to help INSPYR stand up the business in their operating environment. We will be paid for those services, and we also plan to continue reducing our overhead costs to align with a smaller, Property Management-focused company. We expect our financial results, post-close, to be noisy for a couple of quarters.”
Interim Co-Chief Executive Officer and Property Management President, Kelly Brown, commented, “Our second quarter Sales from continuing operations, or the Property Management business, of $23.5 million, improved sequentially on seasonality from the first quarter by 12.6%, and declined from last year’s quarter of 8.6%. Gross margins were relatively stable at 35.8% for the second quarter. In addition to implementing cost reduction measures that Keith addressed, we are also re-baselining Property Management costs to align more closely with revenue and investing in strategic initiatives to drive revenue and profitability in our business. Specifically, we are implementing AI-powered sales and recruiting tools that are expected to be operational by the middle of the fourth quarter.”
Conference Call
BGSF will discuss its second quarter 2025 financial results during a conference call and webcast at 9:00 a.m. ET on August 7, 2025. Interested participants may dial 1-888-506-0062 (Toll Free) or 1-973-528-0011 (International). A replay of the call will be available until August 21, 2025. To access the replay, please dial 1-877-481-4010 (Toll Free), or 1-919-882-2331 (International) and enter access code 52558. The live webcast and archived replay are accessible from the investor relations section of the Company’s website at https://investor.bgsf.com/events-and-presentations/default.aspx
About BGSF
BGSF provides consulting, managed services and professional workforce solutions to a variety of industries through its various divisions in IT, Finance & Accounting, Managed Solutions, and Property Management. BGSF has integrated several regional and national brands achieving scalable growth. The Company was ranked by Staffing Industry Analysts as the 97th largest U.S. staffing company and the 49th largest IT staffing firm in 2024. The Company’s disciplined acquisition philosophy, which builds value through both financial growth and the retention of unique and dedicated talent within BGSF’s family of companies, has resulted in a seasoned management team with strong tenure and the ability to offer exceptional service to our field talent and client partners while building value for investors. For more information on the Company and its services, please visit its website at www.bgsf.com.
Previously Announced Equity Purchase Agreement
On June 16, 2025, BGSF announced that it had signed a definitive agreement to sell its Professional Division to INSPYR Solutions (“INSPYR”). The proposed transaction is subject to the satisfaction of customary closing conditions, including but not limited to the approval of BGSF’s stockholders. For additional information associated with the transaction, please see BGSF’s filings from time to time with the Securities and Exchange Commission.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Such forward-looking statements include, but are not limited to, statements regarding the proposed transaction, obtaining customary shareholder approval, satisfying closing conditions, the closing, including its timing, of the sale of BGSF, Inc.’s Professional Division, the use of proceeds of the sale, the projected operational and financial performance of BGSF and its various subsidiaries, including following the sale of BGSF’s Professional Division, its offerings of services and solutions and developments and reception of its services and solutions by client partners, and BGSF’s expectations, hopes, beliefs, intentions, plans, prospects, or strategies regarding the future revenue and the business plans of BGSF’s management team. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “endeavor,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would,” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of BGSF considering their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on BGSF as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting BGSF will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the closing conditions for the sale of BGSF’s Professional Division not being satisfied, the ability of the parties to close the transaction on the expected closing timeline or at all, the nature, cost, or outcome of any legal proceedings relating to the transaction, the impact of the contemplated transaction on our stock price, the ability of BGSF to service or otherwise pay its debt obligations, including in the event the closing does not occur, the mix of services or solutions utilized by BGSF’s client partners and such client partners’ needs for these services or solutions, market acceptance of new offerings of services or solutions, the ability of BGSF to expand what it does for existing client partners as well as to add new client partners, whether BGSF will have sufficient capital to operate as anticipated, the impact the transaction or its announcement may have on BGSF’s operations, team members, field talent, client partners, and other constituents, the demand for BGSF’s services and solutions, economic activity in BGSF’s industry and in general, and certain risks, uncertainties, and assumptions described in BGSF’s most recently filed Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q under the heading “Risk Factors.” Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. BGSF undertakes no obligation to update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as may be required under applicable securities laws.
Additional Information About the Equity Purchase Agreement and Where to Find It
In connection with the proposed transaction, BGSF filed with the Securities and Exchange Commission (the “SEC”) on July 25, 2025 a definitive proxy statement and other relevant documents, and mailed to BGSF’s shareholders a definitive proxy statement and other relevant documents on or about August 5, 2025. BEFORE MAKING ANY VOTING DECISION, BGSF’S SHAREHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT IN ITS ENTIRETY AND ANY OTHER DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE IN THE DEFINITIVE PROXY STATEMENT BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES TO THE PROPOSED TRANSACTION. Investors and shareholders may obtain a free copy of documents filed by BGSF with the SEC at the SEC’s website at www.sec.gov. In addition, investors and shareholders may obtain a free copy of BGSF’s filings with the SEC from BGSF’s website at https://investor.bgsf.com/financials/sec-filings/default.aspx, or by sending a written request to BGSF’s Corporate Secretary at our principal executive offices at 5850 Granite Parkway, Suite 730, Plano, Texas 75024.
Participants in the Solicitation
This communication is not a solicitation of proxies in connection with the proposed transaction. BGSF, its directors, and certain of its executive officers and employees may be deemed to be participants in soliciting proxies from its shareholders in connection with the proposed transaction. Information regarding BGSF’s directors and executive officers is contained in the most recent Annual Report on Form 10-K filed with the SEC. More detailed information regarding the identity of potential participants in the solicitation of BGSF’s shareholders in connection with the proposed transaction, and their direct or indirect interests, by securities, holdings, or otherwise, is set forth in the definitive proxy statement and other materials relating to the proposed transaction filed with the SEC. You may obtain free copies of these documents using the sources indicated above in Additional Information and Where to Find It.
CONTACT:
Steven Hooser or Sandy Martin Three Part Advisors ir@BGSF.com 214.872.2710 or 214.616.2207
CONSOLIDATED BALANCE SHEETS (in thousands, except share amounts)
2025
2024
(unaudited)
(audited)
ASSETS
Current assets
Cash and cash equivalents
$
2,777
$
32
Accounts receivable (net of allowance for credit losses of $1,156 and $910, respectively)
13,637
17,148
Prepaid expenses
1,687
1,600
Other current assets
2,029
2,213
Current assets of discontinued operations
27,473
24,354
Total current assets
47,603
45,347
Property and equipment, net
299
608
Other assets
Deposits
1,996
2,003
Software as a service, net
3,651
4,068
Deferred income taxes, net
9,227
7,849
Right-of-use asset – operating leases, net
856
1,083
Intangible assets, net
3,911
4,385
Goodwill
1,074
1,074
Noncurrent assets of discontinued operations
81,075
83,694
Total other assets
101,790
104,156
Total assets
$
149,692
$
150,111
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable
$
1,368
$
80
Accrued payroll and expenses
7,086
4,868
Long-term debt, current portion (net of debt issuance costs of $18 and $24, respectively)
3,807
3,801
Accrued interest
510
223
Income taxes payable
295
212
Convertible note
4,368
4,368
Lease liabilities, current portion
474
544
Current liabilities of discontinued operations
11,093
11,825
Total current liabilities
29,001
25,921
Line of credit (net of debt issuance costs of $256 and $770, respectively)
7,744
5,625
Long-term debt, less current portion (net of debt issuance costs of $149 and $198, respectively)
30,664
32,527
Lease liabilities, less current portion
506
698
Noncurrent liabilities of discontinued operations
3,491
3,071
Total liabilities
71,406
67,842
Commitments and contingencies
Preferred stock, $0.01 par value per share, 500,000 shares authorized, -0- shares issued and outstanding
–
–
Common stock, $0.01 par value per share; 19,500,000 shares authorized 11,158,828 and 11,038,623 shares issued and outstanding, respectively, net of 3,930 shares of treasury stock, at cost, respectively.
55
53
Additional paid in capital
70,733
70,260
Retained earnings
7,498
11,956
Total stockholders’ equity
78,286
82,269
Total liabilities and stockholders’ equity
$
149,692
$
150,111
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share and dividend amounts)
For the Thirteen and Twenty-six Week Periods Ended June 29, 2025 and June 30, 2024
Thirteen Weeks Ended
Twenty-six Weeks Ended
2025
2024
2025
2024
Revenues
$
23,506
$
25,726
$
44,389
$
50,273
Cost of services
15,096
16,130
28,419
31,334
Gross profit
8,410
9,596
15,970
18,939
Selling, general, and administrative expenses
12,576
10,739
21,580
21,001
Depreciation and amortization
259
332
588
671
Operating loss
(4,425
)
(1,475
)
(6,198
)
(2,733
)
Interest expense, net
(1,829
)
(1,105
)
(2,931
)
(2,386
)
Loss from continuing operations before income taxes
(6,254
)
(2,580
)
(9,129
)
(5,119
)
Income tax benefit from continuing operations
1,392
498
2,031
989
Net loss from continuing operations
(4,862
)
(2,082
)
(7,098
)
(4,130
)
Income from discontinued operations:
Income from discontinued operations
1,309
1,601
3,377
3,319
Income tax expense
(183
)
(280
)
(737
)
(742
)
Net loss
$
(3,736
)
$
(761
)
$
(4,458
)
$
(1,553
)
Net (loss) income per share – basic:
Net loss from continuing operations
$
(0.44
)
$
(0.19
)
$
(0.65
)
$
(0.38
)
Net income from discontinued operations:
Income
0.12
0.15
0.31
0.31
Income tax expense
(0.02
)
(0.03
)
(0.07
)
(0.07
)
Net loss per share – basic
$
(0.34
)
$
(0.07
)
$
(0.41
)
$
(0.14
)
Net (loss) income per share-diluted:
Net loss from continuing operations
$
(0.44
)
$
(0.19
)
$
(0.65
)
$
(0.38
)
Net income from discontinued operations:
Income
0.12
0.15
0.31
0.31
Income tax expense
(0.02
)
(0.03
)
(0.07
)
(0.07
)
Net loss per share – diluted
$
(0.34
)
$
(0.07
)
$
(0.41
)
$
(0.14
)
Weighted-average shares outstanding:
Basic
11,019
10,880
10,986
10,858
Diluted
11,019
10,880
10,986
10,858
Cash dividends declared per common share
$
–
$
–
$
–
$
0.15
PROPERTY MANAGEMENT SEGMENT (dollars in thousands)
Thirteen Weeks Ended
Twenty-six Weeks Ended
June 29, 2025
June 30, 2024
June 29, 2025
June 30, 2024
Contract field talent
$
23,000
$
25,272
$
43,279
$
49,332
Contingent placements
506
454
1,110
941
Revenue
23,506
25,726
44,389
50,273
Compensation and related
15,058
16,090
28,344
31,254
Other
38
40
75
80
Gross profit
8,410
9,596
15,970
18,939
Selling:
Compensation
4,195
4,771
8,121
9,321
Advertising, occupancy, and travel
447
564
825
908
Software, insurance, and professional fees
296
336
669
632
Other
1,806
674
2,176
1,374
Contributions to overhead
1,666
3,251
4,179
6,704
General and administrative:
Compensation
2,184
2,365
4,245
4,678
Software
828
590
1,525
1,226
Professional fees
569
482
1,111
932
Strategic alternatives review
1,613
280
1,634
349
Other
638
677
1,273
1,580
Depreciation and amortization
259
332
588
671
Operating loss
(4,425
)
(1,475
)
(6,197
)
(2,732
)
Interest expense, net
(1,829
)
(1,105
)
(2,931
)
(2,386
)
Income tax benefit from continuing operations
1,392
498
2,031
989
Net loss from continuing operations
$
(4,862
)
$
(2,082
)
$
(7,097
)
$
(4,129
)
Capital expenditures
$
13
$
432
$
13
$
863
Total assets
$
41,881
$
50,240
$
41,881
$
50,240
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands)
For the Twenty-six Week Periods Ended June 29, 2025 and June 30, 2024
2025
2024
Cash flows from operating activities
Net loss
$
(4,458
)
$
(1,553
)
Net income from discontinued operations
(2,640
)
(2,577
)
Adjustments to reconcile net loss to net cash provided by activities:
Depreciation
58
83
Amortization
530
588
Software as a service
425
328
Loss on disposal of property and equipment
6
–
Amortization of debt issuance costs
598
89
Provision for credit losses
1,656
1,016
Share-based compensation
305
439
Deferred income taxes, net of acquired deferred tax liability
(1,378
)
1,436
Net changes in operating assets and liabilities:
Accounts receivable
1,851
5,948
Prepaid expenses
(87
)
616
Other current assets
(393
)
820
Deposits
8
593
Accounts payable
1,288
160
Accrued payroll and expenses
3,263
(867
)
Accrued interest
287
(218
)
Income taxes receivable
(384
)
(771
)
Other current liabilities
–
2,116
Operating leases
(33
)
(33
)
Net cash provided by continuing operating activities
2,962
14,585
Net cash provided by discontinued operating activities
253
132
Net cash provided by operating activities
3,215
14,717
Cash flows from investing activities
Capital expenditures
(13
)
(863
)
Net cash used in continuing investing activities
(13
)
(863
)
Net cash used in discontinued investing activities
(63
)
(132
)
Net cash used in investing activities
(76
)
(995
)
Cash flows from financing activities
Net borrowings (payments) under line of credit
1,604
(10,808
)
Principal payments on long-term debt
(1,913
)
(850
)
Payments of dividends
–
(1,639
)
Issuance of ESPP shares
134
244
Issuance of shares under the 2013 Long-Term Incentive Plan
–
102
Payments of debt issuance costs
(29
)
(545
)
Net cash used in continuing financing activities
(204
)
(13,496
)
Net change in cash and cash equivalents of continuing operations
2,745
226
Cash and cash equivalents, beginning of period
32
–
Cash and cash equivalents, end of period
$
2,777
$
226
Supplemental cash flow information:
Cash paid for interest, net
$
1,950
$
2,417
Cash paid for taxes, net of refunds
$
739
$
636
NON-GAAP FINANCIAL MEASURES
The financial results of BGSF, Inc. are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the U.S. Securities and Exchange Commission. To help the readers understand our financial performance, we supplements our GAAP financial results with Adjusted EBITDA and Adjusted EPS.
A non-GAAP financial measure is a numerical measure of a company’s financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP in the statement of income, balance sheet or statement of cash flows of a company. Adjusted EBITDA and Adjusted EPS are not measurements of financial performance under GAAP and should not be considered as alternatives to net income, net income per diluted share, operating income, or any other performance measure derived in accordance with GAAP, or as alternatives to cash flow from operating activities or measures of our liquidity. We believe that Adjusted EBITDA and Adjusted EPS are useful performance measures and are used by us to facilitate a comparison of our operating performance on a consistent basis from period-to-period and to provide for a more complete understanding of factors and trends affecting our business than measures under GAAP can provide alone. In addition, the financial covenants in our credit agreement are based on EBITDA as defined in the credit agreement.
We define “Adjusted EBITDA” as earnings before interest expense, income taxes, depreciation and amortization expense, costs associated with the evaluation of potential strategic alternatives (“strategic alternatives review”), software as a service costs, and certain non-cash expenses such as share-based compensation expense, as well as certain specific events that management does not consider in assessing our on-going operating performance.
We define “Adjusted EPS” as diluted earnings per share eliminating amortization expense of intangible assets from acquisitions, the strategic alternatives review, software as a service costs, and certain non-cash expenses such as share-based compensation expense, as well as certain specific events that management does not consider in assessing our on-going operating performance, net of the respective income tax effect.
Reconciliation of Net Loss to Adjusted EBITDA (dollars in thousands)
Thirteen Weeks Ended
Twenty-six Weeks Ended
Thirteen Weeks Ended
June 29, 2025
June 30, 2024
June 29, 2025
June 30, 2024
March 30, 2025
Net loss from continuing operations
$
(4,862
)
$
(2,082
)
$
(7,098
)
$
(4,130
)
$
(2,245
)
Income tax benefit
(1,392
)
(498
)
(2,031
)
(989
)
(630
)
Interest expense, net
1,829
1,105
2,931
2,386
1,102
Operating loss
(4,425
)
(1,475
)
(6,198
)
(2,733
)
(1,773
)
Depreciation and amortization
259
332
588
671
329
Share-based compensation
137
220
305
439
168
Strategic alternatives review
1,613
280
1,634
349
20
Software as a service2
291
180
425
328
134
Aged receivable adjustment
980
199
1,070
324
90
Adjusted EBITDA from continuing operations
(1,145
)
(264
)
(2,176
)
(622
)
(1,032
)
Adjusted EBITDA Margin (% of revenue)
(4.9)
%
(1.0)
%
(4.9)
%
(1.2)
%
(5.4)
%
Income from discontinued operations
1,126
1,321
2,640
2,577
1,522
Adjustments to discontinued operations
1,142
1,901
3,090
4,001
1,405
Adjusted EBITDA from discontinued operations
2,268
3,222
5,730
6,578
2,927
Adjusted EBITDA, net
$
1,123
$
2,958
$
3,554
$
5,956
$
1,895
2 We capitalize direct costs incurred in cloud computing implementation from hosting arrangements, which are reported as a Software as a service and are expensed as incurred in selling, general, and administrative expenses.
Reconciliation of Net Loss EPS to Adjusted EPS
Thirteen Weeks Ended
Twenty-six Weeks Ended
Thirteen Weeks Ended
June 29, 2025
June 30, 2024
June 29, 2025
June 30, 2024
March 30, 2025
Net loss from continuing operations per diluted share
$
(0.44
)
$
(0.19
)
$
(0.65
)
$
(0.38
)
$
(0.21
)
Income tax benefit
(0.13
)
(0.05
)
(0.18
)
(0.09
)
(0.06
)
Interest expense, net
0.17
0.10
0.27
0.22
0.10
Operating loss
(0.40
)
(0.14
)
(0.56
)
(0.25
)
(0.17
)
Depreciation and amortization
0.02
0.03
0.05
0.06
0.03
Share-based compensation
0.01
0.02
0.03
0.04
0.02
Strategic alternatives review
0.15
0.03
0.15
0.03
–
Software as a service2
0.03
0.02
0.04
0.03
0.01
Adjusted EPS from continuing operations
(0.19
)
(0.04
)
(0.29
)
(0.09
)
(0.11
)
Adjusted EPS from discontinued operations
0.21
0.29
0.52
0.60
0.27
Adjusted EPS
$
0.02
$
0.25
$
0.23
$
0.51
$
0.16
2 We capitalize direct costs incurred in cloud computing implementation from hosting arrangements, which are reported as a Software as a service and are expensed as incurred in selling, general, and administrative expenses.
